Shin Nippon Biomedical Laboratories2395 
$8.470.16%24h
0.16%24h
Global rank13710
Market cap$352.74M
Change 7d5.41%
YTD Performance-26.95%
SP500 benchmarkUnderperform
P/E0.06
P/S2.04
Revenue$173.12M
Earnings$41.75M
Dividend yield-
Main Sector
Healthcare
Shin Nippon Biomedical Laboratories 2395 Total Debt
2395 Total Debt in 2022: $67.88M
According to Shin Nippon Biomedical Laboratories latest financial reports the total debt is $67.88M, an increase of 58.78% to 2022. At the end of 2022 company had $42.75M total debt. This figure represents the debts and financial obligations that Shin Nippon Biomedical Laboratories combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Shin Nippon Biomedical Laboratories 2395 Total Debt History from 2023 to 2022
-
Value:-
2395 Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $67.88M | 58.78% |
| 2022 | $42.75M | -32.65% |
| 2021 | $63.47M | 3.08% |
| 2020 | $61.58M | 93.88% |
| 2019 | $31.76M | - |
View the Top Total Debt Stocks 
